Hope-Focused Motivational Interviewing in Cancer Patients

N/AEnrolling By InvitationNCT07585838

Saglik Bilimleri Universitesi46 enrolled

Overview

This study aims to examine the effects of hope-focused motivational interviewing on levels of hope, self-efficacy, and self-compassion in patients with cancer receiving radiotherapy, using a randomized controlled design.

This study is designed as a randomized controlled experimental study with a pretest-posttest and follow-up design. It will be conducted with individuals diagnosed with cancer who are receiving inpatient care in the Radiation Oncology unit of a City Hospital. According to the G\*Power analysis, a minimum of 46 participants (intervention = 23, control = 23) will be included in the study. The computer-aided https://www.random.org/integers/ program will be used to assign the intervention and control groups without bias. The intervention group will receive a "Hope-Focused Motivational Interviewing" program consisting of four sessions delivered twice weekly, while the control group will receive routine treatment and care. Data will be collected using the "Information Form," "Herth Hope Index," "Brief Self-Compassion Scale," and "General Self-Efficacy Scale." Measurements will be obtained before and after the intervention. To minimize bias, data will be collected via Google Forms. The first page of the form will include information about the study along with an informed consent statement, and participants will be required to provide their consent before proceeding. Participants who agree to take part in the study will complete the questionnaires within approximately 15-20 minutes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Motivational Intervention Cancer Hope Self-Compassion Self-Efficacy

Interventions

Hope-Focused Motivational InterviewingBEHAVIORAL

Participants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly. Each session will last approximately 30-40 minutes. The program includes the following components: (1) exploration of hope and goal setting, (2) enhancement of self-efficacy, (3) development of self-compassion, and (4) coping with barriers and creating a sustainable coping plan. Assessments will be conducted at baseline (pre-test), post-intervention, and at 1-month follow-up.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Being 18 years of age or older * Having a diagnosis of Stage I-III cancer according to the TNM staging system Receiving radiotherapy at the study center (including adjuvant, neoadjuvant, or definitive RT) * Being in the first week of the radiotherapy process * Being able to read and understand Turkish and communicate at a level sufficient to participate in interviews * Agreeing to attend the intervention sessions at scheduled times and providing written informed consent Exclusion Criteria: * Presence of metastatic disease (Stage IV) or recurrent cancer * Receiving concurrent chemotherapy during the radiotherapy process * Presence of severe psychiatric conditions that may interfere with participation or the safe implementation of the intervention (e.g., psychotic disorders, bipolar disorder in the manic phase, or severe major depression) * Presence of moderate to severe cognitive impairment/dementia, significant attention or concentration problems, or neurological conditions that may compromise the reliability of responses * Severe hearing or speech impairments or communication difficulties that would prevent participation in interviews or completion of questionnaires (if appropriate support cannot be provided) * Participation in another structured psychosocial intervention program (e.g., hope-based, psychoeducational, or psychotherapeutic programs) during the study period

Locations (1)

Bartın University

Bartın, Bartın, Turkey (Türkiye)

Outcomes

Primary Outcomes

Herth Hope Index

The scale consists of 12 items and three subscales: (1) temporality and future, (2) positive readiness and expectancy, and (3) interconnectedness with self and others. Items are rated on a 4-point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree). The "temporality and future" subscale (items 1, 2, 6, and 11) assesses the temporal dimension of hope; the "positive readiness and expectancy" subscale (items 4, 7, 10, and 12) reflects the emotional-behavioral aspects of hope; and the "interconnectedness" subscale (items 3, 5, 8, and 9) measures relational and contextual aspects of hope. Items 3 and 6 are negatively worded and are reverse scored. The total scale score is obtained by summing responses to all items, while subscale scores are calculated by summing the corresponding items. Total scores range from 12 to 48, with higher scores indicating greater levels of hope.

Time frame: Baseline, immediately after the 2-week intervention, and 1 month post-intervention

Secondary Outcomes

Brief Self-Compassion Scale

The Brief Self-Compassion Scale consists of 12 items rated on a 5-point Likert scale. Items 1, 4, 8, 9, 11, and 12 are reverse scored. The scale comprises two factors: self-compassion and self-criticism (or maladaptive self-compassion). Total scores range from 12 to 60, with higher scores indicating greater levels of self-compassion.

Time frame: Baseline, immediately after the 2-week intervention, and 1 month post-intervention

General Self-Efficacy Scale

The General Self-Efficacy Scale consists of 17 items rated on a 5-point Likert scale. Items 2, 4, 5, 6, 7, 10, 11, 12, 14, 16, and 17 are reverse scored. The scale includes three subscales: initiation, persistence, and maintenance effort. Total scores range from 17 to 85, with higher scores indicating higher levels of self-efficacy.

Time frame: Baseline, immediately after the 2-week intervention, and 1 month post-intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.